Blar i forfatter "Hofvind, Solveig"

Viser treff 1-10 av 10

    • Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway 

      Tsuruda, Kaitlyn; Larsen, Marthe; Roman, Marta; Hofvind, Solveig (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-12-21)
      <p><b>Background</b> False-positive screening results are an inevitable and commonly recognized disadvantage of mammographic screening. This study estimated the cumulative probability of experiencing a first false-positive screening result in women attending 10 biennial screening rounds in BreastScreen Norway, which targets women aged 50 to 69 years. <p><b>Methods</b> This retrospective ...

    • LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer 

      Sas-Chen, Aldema; Aure, Miriam Ragle; Leibovich, Limor; Carvalho, Silvia; Enuka, Yehoshua; Körner, Cindy; Polycarpou-Schwarz, Maria; Lavi, Sara; Nevo, Nava; Kuznetsov, Yuri; Yuan, Justin; Azuaje, Francisco; Ulitsky, Igor; Diederichs, Sven; Wiemann, Stefan; Yakhini, Zohar; Kristensen, Vessela N.; Børresen-Dale, Anne-Lise; Yarden, Yosef; Sauer, Torill; Geisler, Jürgen; Hofvind, Solveig; Bathen, Tone Frost; Borgen, Elin; Engebråten, Olav; Fodstad, Øystein; Garred, Øystein; Geitvik, Gry; Kåresen, Rolf; Naume, Bjørn; Mælandsmo, Gunhild; Russnes, Hege Elisabeth Giercksky; Schlichting, Ellen; Sørlie, Therese; Lingjærde, Ole Christian; Sahlberg, Kristine Kleivi; Skjerven, Helle; Fritzman, Britt (Journal article; Tidsskriftartikkel; Peer reviewed, 2016-09-01)
      Long noncoding RNAs (lncRNAs) are emerging as regulators of gene expression in pathogenesis, including cancer. Recently, lncRNAs have been implicated in progression of specific subtypes of breast cancer. One aggressive, basal-like subtype associates with increased EGFR signaling, while another, the HER2-enriched subtype, engages a kin of EGFR Based on the premise that EGFR-regulated lncRNAs might ...

    • Long-term quality of life among breast cancer survivors eligible for screening at diagnosis: a systematic review and meta-analysis 

      Moshina, Nataliia; Falk, Ragnhild Sørum; Hofvind, Solveig (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-09-21)
      Objectives - This study aimed to explore the long-term quality of life (QoL) among breast cancer survivors eligible for mammographic screening at diagnosis and compare that to QoL among women with no history of breast cancer.<p> <p>Study design - Systematic review and meta-analysis.<p> <p>Methods - A systematic review of randomised controlled trials and observational studies published between ...

    • Lower attendance rates in BreastScreen Norway among immigrants across all levels of socio-demographic factors: a population-based study 

      Le, Mary Thuy An; Hofvind, Solveig; Tsuruda, Kaitlyn; Braaten, Tonje; Bhargava, Sameer (Journal article; Tidsskriftartikkel; Peer reviewed, 2018-06-03)
      <i>Background:</i> Several studies have shown that immigrants attend mammographic screening less frequently than non-immigrants. Studies have also shown that attendance is influenced by socio-demographic factors. We aimed to describe the relationship between socio-demographic factors and first attendance among immigrant and non-immigrant women invited to BreastScreen Norway.<p> <p><i>Methods:</i> ...

    • Mammographic screening in Sami speaking municipalities and a control group. Are early outcome measures influenced by ethnicity? 

      Norum, Jan; Hofvind, Solveig; Nieder, Carsten; Schnell, Edrun Andrea; Broderstad, Ann Ragnhild (Journal article; Tidsskriftartikkel; Peer reviewed, 2012-04-16)
      Objectives. Female citizens of Sami (the indigenous people of Norway) municipalities in northern Norway have a low risk of breast cancer. The objective of this study was to describe the attendance rate and outcome of the Norwegian Breast Cancer Screening Program (NBCSP) in the Sami-speaking municipalities and a control group.<p> <p>Study design. A retrospective registry-based study.<p> <p>Methods. ...

    • Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life 

      Sandvei, Marie Søfteland; Vatten, Lars Johan; Bjelland, Elisabeth Krefting; Eskild, Anne; Hofvind, Solveig; Ursin, Giske; Opdahl, Signe (Journal article; Tidsskriftartikkel; Peer reviewed, 2018-08-06)
      It is not known whether increased breast cancer risk caused by menopausal hormone therapy (HT) depends on body mass patterns through life. In a prospective study of 483,241 Norwegian women aged 50–69 years at baseline, 7656 women developed breast cancer during follow-up (2006–2013). We combined baseline information on recalled body mass in childhood/adolescence and current (baseline) body mass index ...

    • Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway. 

      Botteri, Edoardo; Støer, Nathalie Charlotte; Sakshaug, Solveig; Graff-Iversen, Sidsel; Vangen, Siri; Hofvind, Solveig; de Lange, Thomas; Bagnardi, Vincenzo; Ursin, Giske; Weiderpass, Elisabete (Journal article; Tidsskriftartikkel; Peer reviewed, 2017-11-15)
      Objectives: <br> With the present study, we aimed to investigate the association between menopausal hormone therapy (HT) and risk of colorectal cancer (CRC). <br> Setting: <br> Cohort study based on the linkage of Norwegian population-based registries. <br> Participants: <br> We selected 466822 Norwegian women, aged 55–79, alive and residing in Norway as of 1 January 2004, and we followed ...

    • Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role? 

      Botteri, Edoardo; Støer, Nathalie; Sakshaug, Solveig; Graff-Iversen, Sidsel; Vangen, Siri; Hofvind, Solveig; Ursin, Giske; Weiderpass, Elisabete (Journal article; Tidsskriftartikkel; Peer reviewed, 2017-07-07)
      The association between use of menopausal hormone therapy (HT) and occurrence of skin malignant melanoma (SMM) is controversial. We investigated the issue in a nationwide cohort of 684,696 Norwegian women, aged 45–79 years, followed from 2004 to 2008. The study was based on linkage between Norwegian population registries. Multivariable Poisson regression models were used to estimate the effect of ...

    • Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway 

      Moshina, Nataliia; Falk, Ragnhild Sørum; Botteri, Edoardo; Larsen, Marthe; Akslen, Lars Andreas; Cairns, John Alexander; Hofvind, Solveig (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-10-26)
      Purpose - Breast cancers detected at screening need less aggressive treatment compared to breast cancers detected due to symptoms. The evidence on the quality of life associated with screen-detected versus symptomatic breast cancer is sparse. This study aimed to compare quality of life among Norwegian women with symptomatic, screen-detected and interval breast cancer, and women without breast cancer ...

    • Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study 

      Tsuruda, Kaitlyn; Veierød, Marit Bragelien; Houssami, Nehmat; Wåde, Gunvor Gipling; Mangerud, Gunhild; Hofvind, Solveig (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-12-14)
      Objective To investigate conceptual knowledge about mammographic screening among Norwegian women. Design We administered a cross-sectional, web-based survey. We used multiple-choice questions and a grading rubric published by a research group from Australia. Setting Our Norwegian-language survey was open from April to June 2020 and targeted women aged 45–74 years. Participants 2033 women ...